Skip to main content
Figure 3 | BMC Infectious Diseases

Figure 3

From: A randomized controlled phase IIb wound healing trial of cutaneous leishmaniasis ulcers with 0.045% pharmaceutical chlorite (DAC N-055) with and without bipolar high frequency electro-cauterization versus intralesional antimony in Afghanistan

Figure 3

Wound closure time in PP patients of Group I versus Group II versus Group III. Statistically significant difference between Group II versus Group I (p = 0.000001, Log-Rank [Mantel-Cox] test). Statistical significant differences were found between all groups (see Table 6).

Back to article page